Proctology diseases remain an urgent problem of modern medicine due to the prevalence of destructive inflammatory processes in the rectum and the complexity of the course of pharmacotherapy of these pathologies [7, [9] [10] [11] [12] . Taking into account that the range of domestic medicines for treating diseases of the rectum is insufficient there is a need to create new drugs in the most rational and effective dosage form in proctologysuppositories [8] .
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At the National University of Pharmacy (Kharkiv) under the supervision of prof. S.I.Merzlikin (±)-cys-3-(2´-bеnzoimidazolyl)-1,2,2-trimethyl-cyclopentancarboxylic acid has been synthesized; on its basis the original antidiabetic drug "Diacamph" has been developed. The results further pharmacological studies have shown that diacamph reveals a pronounced reparative action [5] . Taking into account that diseases of the rectum are accompanied by inflammatory and destructive processes the use of diacamph in proctology is appropriate.
At the Department of Industrial Technology of Drugs of the National University of Pharmacy a new drug in the form of rectal suppositories with diacamph as an active substance has been developed [6] . Based on the biopharmaceutical research it has been determined that the rational suppository base is an alloy of proxanol-268 with PEO-400 and propylene glycol [2] .
The aim of this work is to study the crystallographic and thermogravimetric characteristics of the active substance and the full composition of suppositories for selecting the rational conditions of the technological process.
Materials and Methods
Crystallographic properties of the powder was determined by optical crystallography and microphotography using a Kruss MBL 2100 microscope (Germany) with an eyepiece micrometer with magnification of 150 times. The object of the study was the active ingredient -diacamph. Crystals of diacamph original powder, crushed pure diacamph and suspensions of crushed diacamph in propylene glycol were studied.
The thermogravimetric analysis was performed on a Q -1000 derivatograph of the system by F.Paulik, J.Paulik, L.Yerdey with a platinum to platinum/rhodium thermocouple by heating samples in ceramic crucibles from 20 to 250°C. Aluminum oxide served as a standard. The sample weight was 30 mg. Such curves as T (temperature changes), W (weight change), DTF (differential curve of thermal factors change), DW (differential curve of weight change) were recorded. The active substance -diacamph, the suppository base and the full composition of suppositories were subjected to thermogravimetric analysis.
Results and Discussion
To select the rational technology of introduction of the active ingredient diacamph to the dosage form its crystallographic characteristics were studied.
The visual examination under a microscope allows to observe the shape and structure of particles to obtain the preliminary data concerning their maximal and minimal sizes, and it is especially important when developing the technology of new dosage forms [3] [4] . Taking into account that diacamph is in the suppository base as a suspension we conducted the study in order to select the rational technology of its introduction into the composition of suppositories.
The substance of diacamph is rod-shaped crystals with the size of 100-400 microns (Fig. 1) . Crystals of diacamph is quite large, so a uniform distribution of the active ingredient in the base without crushing is impossible. When crushing diacamph in a dry form a mixture of particles with an uneven particle size was obtained (Fig. 2) . And when crushing diacamph with propylene glycol (a liquid, in which the substance is in a semisoluble state) a fine homogeneous suspension was ob-tained. Therefore, in the manufacture of suppositories diacamph must first triturated in a dry form and then with propylene glycol; it will provide partial dissolution of the substance at first, and when exceeding the limit of solubility there will be an even distribution of it in the base (Fig. 3) .
In order to determine the optimal technology of the drug preparation we studied the decomposition temperature of diacamph and the suppository base included in the suppositories. These parameters allow to select the optimal temperature mode for the suppository base preparation and introduction of the active substance into its composition without destroying the structure of the active substance and changes of its pharmacological effect [1, 3] . The thermograms of the test samples are given in Fig. 4-5 .
Our studies show that diacamph (Fig. 4) does not undergo any change when heated to the temperature of 250°C: thermal effects and loss in weight are absent. This substance is stable, therefore, it does not require special temperature conditions when preparing suppositories.
The suppository base (Fig. 5, A) is melted at the temperature of 35 o C. When heated above 62 o C a gradual loss in weight starts; at first, it is characterized by evaporation of the liquid components, and then the thermal degradation of proxanol occurs.
A test sample of the full composition of rectal suppositories (Fig. 5, B) melts at 37°C. When increasing the temperature from 63°C to 110 C there is a gradual loss in weight due to evaporation of the liquid components of the base. In the temperature range of 110-170°C the thermooxidative degradation of proxanol begins.
Thus, on the basis of the research conducted a combined suppository base (60°C) appeared to be the least heat-resistant because it is composed of liquid components in large quantities. Therefore, when preparing the suppository mass it is important not to allow its heating above 60 o C. The thermogram of the full composition of suppositories has shown the complete identity of thermal effects of individual substances, indicating the absence of interaction between the active substance and excipients in the dosage form proposed. CONCLUSIONS 1. The crystallographic characteristics of the diacamph original powder crystals, crushed diacamph crystals and the suspension of diacamph in propylene glycol have been studied, and the optimal technology of its introduction to the suppositories has been selected.
2. The thermogravimetric analysis of suppositories and individual components of the suppository base has been performed, the maximum heating temperature of the suppository mass has been determined. The thermogram of the full composition of suppositories has shown the complete identity of thermal effects of individual substances, indicating the absence of interaction between the active substance and excipients in this dosage form when manufacturing suppositories. 
